Percutaneous Endoscopic Tracheal Plug/Unplug for CDH (Congenital Diaphragmatic Hernia)
NO_LONGER_AVAILABLE
Conditions studied: Severe Congenital Diaphragmatic Hernia
In brief
Congenital diaphragmatic hernia is an anatomically simple birth defect in which contents of the fetal abdomen migrate into the chest due to incomplete formation of the diaphragm. Herniation of viscera into the chest prevents the fetal lungs from developing and growing to normal size. In the most severe cases, there is significant morbidity and mortality at birth. For these fetuses, fetal intervention may improve outcomes by enabling the lungs to grow enough in utero that they are capable of sustaining life after birth. This unblinded, non-randomized trial will assess the safety and efficacy of the use of the Goldvalve balloon and MiniTorquer microcatheter to perform percutaneous temporary tracheal occlusion to treat severe CDH in utero. The primary outcome variable will be fetal lung growth due to successful 'plugging/unplugging' of the trachea, as determined by serial lung-head ratio (LHR) measurements. Secondary outcome variables include maternal, fetal and neonatal variables, specifically neonatal survival at 90 days of life. For infants who survive beyond 90 days post-delivery, their families will be offered follow-up (up to 2 years of age and possibly beyond) in the Long-term Infant-to-Adult Follow-up Evaluation (LIFE) Clinic at UCSF.
Key facts
- Study ID
- NCT00768703
- Run by
- University of California, San Francisco
- Last updated by the study team
- 2019-03-27
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Confirmed diagnosis of CDH
- Normal fetal echocardiogram
- Normal karyotype
- Fetal liver herniated into the left hemithorax
- Lung-head ratio (LHR) is 1.0 or less, calculated between 24-26 weeks' gestation
- Fetus is between 26 and 28 weeks' gestation
- Singleton pregnancy
- Mother meets psychosocial criteria
- Pre-authorization from third-party payor for fetal intervention, or ability to self-pay.
You may not qualify if…
- Failure to meet all inclusion criteria
- Other congenital anomalies detected on ultrasound
- Contraindication to abdominal surgery or general anesthesia
- Allergy to latex
- Preterm labor, preeclampsia, or uterine anomaly (e.g., large fibroid tumor)
- Family unable or refuses to stay in San Francisco for duration of the tracheal occlusion period and for the duration of the pregnancy as medically necessary.
Where it is running
- University of California, San Francisco Fetal Treatment Center — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.